2023-508471-37-00招募中2 期
A proof-of-concept study with NVDX3, an osteogenic implant of human allogenic origin, in the treatment of low grade degenerative lumbar spondylolisthesis by interbody spine fusion in adults.
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 10
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Denis Dufrane
Scientific
Novadip Biosciences
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
A proof-of-concept study with NVDX3, an osteogenic implant of human allogenic origin, in the treatment of low grade degenerative lumbar spondylolisthesis by interbody spine fusion in adults.CTIS2023-508471-37-00ovadip Biosciences10
进行中（未招募）
1 期
A first-in-human proof-of-concept study with NVDX3, an osteogenic implant of human allogenic origin, in the treatment of distal radius fractures in adults.Distal radius fracturesCTIS2023-508321-27-00ovadip Biosciences10
进行中（未招募）
1 期
Clinical study to evaluate the safety and preliminary efficacy of the autologous 3D osteogenic implant for the treatment of the children patients with congenital pseudarthrosis of the tibiacongenital pseudarthrosis of the tibia (CPT)EUCTR2022-001282-12-BEovadip Biosciences4
进行中（未招募）
1 期
Study of DS-1062a with or without Pembrolizumab in Advanced or Metastatic Non-small Cell Lung Cancer without Actionable Genomic AlterationsEUCTR2021-002555-10-GRDaiichi Sankyo, Inc.740
进行中（未招募）
1 期
Study of DS-1062a with or without Pembrolizumab in Advanced or Metastatic Non-small Cell Lung Cancer without Actionable Genomic AlterationsAdvanced or Metastatic Non-small Cell Lung Cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-002555-10-PTDaiichi Sankyo, Inc.740